ArticleCell cycle (Georgetown, Tex.)2021

Dexmedetomidine upregulates microRNA-185 to suppress ovarian cancer growth via inhibiting the SOX9/Wnt/β-catenin signaling pathway.

Hang Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.